# A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity

> **NCT07876518** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 150 (estimated)

## Conditions studied

- Overweight and/or Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** PF-08656795

## Key facts

- **NCT ID:** NCT07876518
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2028-11-16
- **Final completion:** 2028-11-16
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07876518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07876518, "A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07876518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
